Biomedical Applications of Ionic Liquids and Deep Eutectic Solvents
A special issue of Bioengineering (ISSN 2306-5354).
Deadline for manuscript submissions: closed (31 March 2022) | Viewed by 3037
Special Issue Editors
2. Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA 02138, USA
Interests: gene therapy; bioinspired drug delivery systems; precision medicine; controlled release
Special Issues, Collections and Topics in MDPI journals
2. Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA 02138, USA
Interests: nanomedicine; drug distribution; triggered release; bioinspired drug delivery systems
2. Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA 02138, USA
Interests: drug delivery; polymeric biomaterials; gene therapy; hemostasis
Special Issue Information
Dear Colleagues,
Biomaterials have become a key component of successful drug delivery, tissue regeneration, and disease diagnostics. While recent developments in smart biomaterials have made major contributions to broadening the current repertoire, there is still an unmet immediate and long-term need for advanced systems with specific functionalities to overcome physicochemical and biological barriers. Ionic liquids and deep eutectic solvents in particular have previously been extensively utilized to facilitate energy storage and gas separation, owing to their notable properties, including thermal stability, conductivity, viscosity, solubility, and antimicrobial effect. Recently, the exploitation of these properties has also spurred their use in pharmaceutical technologies, further leading to investigations in a wide spectrum of biomedical applications.
This Special Issue of Bioengineering on “Biomedical Applications of Ionic Liquids and Deep Eutectic Solvents” will cover original research papers and comprehensive reviews that describe the utilization of ionic liquids/deep eutectic solvents in the development of delivery vehicles for a wide range of therapeutics, including small-molecule drugs, biomacromolecules (peptides, proteins, and nucleic acids), and cells, as well as diagnostic systems. Biomedical applications of interest for this Special Issue include but are not limited to the stabilization of drug formulations, biological transport, controlled release, pharmacokinetics, noninvasive treatment, regenerative medicine, and biosensors.
Dr. Jayoung Kim
Dr. Michael Dunne
Dr. Yongsheng Gao
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Bioengineering is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- emulsions
- controlled release
- pharmacokinetics
- nanoparticles
- polymer composites
- ionogels
- patches
- gene delivery
